Connect to other sites within the UBM Medica Network
CRP Levels Predict Survival in RCC Patients on Dialysis
Preoperative levels of C-reactive protein may be as predictive of outcomes as pathological TNM stage or tumor grade for prognosis in renal cell carcinoma.
Communicating With the Troubled Patient
When communicating with the difficult patient doctors are advised to avoid such approaches as snapping, bristling, or even a subtle curling of the lips.
Lung Mass Found in Patient With Recurrent Pneumonia
A 58-year-old smoker with recurrent pneumonia presents with an ill-defined mass in the right lung. What is your diagnosis?
Kidney Mass Found in 48-Year-Old Patient
A 48-year-old woman presents with a left kidney mass. What is your diagnosis?
Cancer Screening Often Excessive in Older Patients
Patients with limited life expectancies often undergo routine cancer screenings despite evidence that they are unlikely to benefit and may experience harm.
Test Could Detect HPV-Related Head and Neck Cancer Recurrence
Researchers have developed a preliminary test using blood and saliva samples to detect disease recurrence in patients with HPV-related head and neck cancer.
Best to Stage Esophageal Cancer After Neoadjuvant Chemo
The stage of esophageal adenocarcinomas after neoadjuvant chemotherapy is predictive of outcomes, rather than the stage determined prior to therapy.
Mutation in Cutaneous Lymphoma Linked to Poor Prognosis
A new study confirms that patients with primary cutaneous diffuse large B-cell lymphoma who have a MYD88 mutation have a shorter disease-specific survival.
Best Methods for ALK Screening in Non–Small-Cell Lung Cancer
A new study sheds light on the prevalence of ALK positive non–small-cell lung cancer and suggests the best methods for screening.
FDA Approves Avastin for Advanced Cervical Cancer
The US Food and Drug Administration has approved bevacizumab (Avastin) for the treatment of patients with recurrent or metastatic cervical cancer.
By clicking Accept, you agree to become a member of the UBM Medica Community.